Rosuvastatin use increases plasma fibrinolytic potential: a randomised clinical trial

We conducted a study to assess the effect of rosuvastatin use on fibrinolysis in patients with previous venous thromboembolism (VTE). This was a post hoc analysis within the STAtins Reduce Thrombophilia (START) study (NCT01613794). Plasma fibrinolytic potential, fibrinogen, plasmin inhibitor, plasmi...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Br J Haematol
Asıl Yazarlar: Schol‐Gelok, Suzanne, de Maat, Moniek P. M., Biedermann, Joseph S., van Gelder, Teun, Leebeek, Frank W. G., Lijfering, Willem M., van der Meer, Felix J. M., Rijken, Dingeman C., Versmissen, Jorie, Kruip, Marieke J. H. A.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley and Sons Inc. 2020
Konular:
Platelets Haemostasis and Thrombosis
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7539918/
https://ncbi.nlm.nih.gov/pubmed/32301122
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjh.16648
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller